Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-081930

Chief Financial Officer acquired 1,550 shares (grant or award)

  • Chief Financial Officer gave up 519 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2025-06-02 Grant or award +775 $71.68 $55,552 13,809 D
Mokari Atabak Chief Financial Officer 2025-06-02 Grant or award +775 14,584 D
Mokari Atabak Chief Financial Officer 2025-06-03 Shares withheld for taxes −519 $71.68 $37,202 14,065 D
Loading xslF345X05/ownership.xml…